Study of AVD275 injection for knee osteoarthritis
Part of Bones, joints & muscles clinical trials.
This trial tests a new injection called AVD275 for people with knee osteoarthritis. It aims to see if the injection is safe and how it works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 75 years old.
- You have had knee pain from osteoarthritis for at least 6 months.
- Your body mass index (BMI) is 40 or less.
- You are able to walk and are generally in good health.
- You have not had certain knee surgeries or injections in the past few months.
- You are not pregnant or nursing, and if you could become pregnant, you use effective birth control.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the safety of an experimental injection called OA-SYS for people with moderate to severe knee osteoarthritis. It may help if you have not had recent injections or certain other health problems.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
This trial tests a new vaccine for people with inflammatory knee osteoarthritis who still have pain despite standard treatments. It aims to see if the vaccine can help reduce pain and inflammation.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This trial tests an injectable medication called RAB001 for people with knee osteoarthritis that hasn't improved with other treatments. The goal is to see if it's safe and helps reduce pain.
This trial tests if a new medication called MAG200, injected into the knee, can reduce pain and improve function in people with moderate to severe knee osteoarthritis. You will receive either the study drug or a placebo (an inactive substance) to compare results.
Hear when a new Osteoarthritis of the Knee trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.